Avience Biomedicals Ltd vs Hemant Surgical Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Avience Biomedicals Ltd is ₹ 240 as of 23 Oct 15:30 . The P/E Ratio of Avience Biomedicals Ltd is 0 as of March 2025 .The P/E Ratio of Hemant Surgical Industries Ltd is 12.9 as of March 2025 . The Market Cap of Avience Biomedicals Ltd is ₹ 0 crore as of March 2025 .The Market Cap of Hemant Surgical Industries Ltd is ₹ 104.03 crore as of March 2025 . The Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Hemant Surgical Industries Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

About Hemant Surgical Industries Ltd

Hemant Surgical Industries Limited was originally incorporated as 'Hemant Surgical Industries Private Limited' dated March 27, 1989, by ROC, Mumbai.
Subsequently, Company was converted into a public limited company and the name of Company was changed to 'Hemant Surgical Industries Limited' vide fresh Certificate of Incorporation dated February 22, 1994 by the Registrar of Companies, Mumbai. Company is in the business of Medical Equipment & Supplies in Mumbai.
Its product basket cover a wide spectrum of equipments and disposables required for Renal Care, Cardiovascular Disease, Respiratory Disease, Critical Care and Radiology and Surgical disposables.
In addition, the Company is providing services for maintenance and in running of 5 dialysis centres. The Company started its operations in 1993 with importing and marketing of medical disposables like meditapes, all over India from JMS Co Ltd.

FAQs for the comparison of Avience Biomedicals Ltd and Hemant Surgical Industries Ltd

Which company has a larger market capitalization, Avience Biomedicals Ltd or Hemant Surgical Industries Ltd?

Market cap of Avience Biomedicals Ltd is 131 Cr while Market cap of Hemant Surgical Industries Ltd is 828 Cr

What are the key factors driving the stock performance of Avience Biomedicals Ltd and Hemant Surgical Industries Ltd?

The stock performance of Avience Biomedicals Ltd and Hemant Surgical Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Avience Biomedicals Ltd and Hemant Surgical Industries Ltd?

As of October 25, 2026, the Avience Biomedicals Ltd stock price is INR ₹240.0. On the other hand, Hemant Surgical Industries Ltd stock price is INR ₹570.0.

How do dividend payouts of Avience Biomedicals Ltd and Hemant Surgical Industries Ltd compare?

To compare the dividend payouts of Avience Biomedicals Ltd and Hemant Surgical Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.